Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

被引：0
|
作者：
Jan J. De Waele
J. Lipman
M. Akova
M. Bassetti
G. Dimopoulos
M. Kaukonen
D. Koulenti
C. Martin
P. Montravers
J. Rello
A. Rhodes
A. A. Udy
T. Starr
S. C. Wallis
J. A. Roberts
机构：
[1] Ghent University Hospital,Department of Critical Care Medicine
[2] The University of Queensland,Burns Trauma and Critical Care Research Centre
[3] Royal Brisbane and Women’s Hospital,Attikon University Hospital
[4] Hacettepe University Hospital,Department of Epidemiology and Preventive Medicine, Monash University
[5] Azienda Ospedaliera Universitaria Santa Maria della Misericordia,CIBERES
[6] University of Athens Medical School,Department of Intensive Care and Hyperbaric Medicine
[7] Helsinki University Hospital,undefined
[8] Australian and New Zealand Intensive Care Research Centre (ANZIC RC),undefined
[9] Hospital Nord,undefined
[10] Centre Hospitalier Universitaire Bichat-Claude Bernard,undefined
[11] Vall d’Hebron Institut of Research,undefined
[12] St George’s Healthcare NHS Trust and St George’s University of London,undefined
[13] The Alfred Hospital,undefined
来源：
Intensive Care Medicine | 2014年 / 40卷
关键词：
β-Lactam antibiotics; Pharmacokinetics; Pharmacodynamics; Critical care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1340 / 1351
页数：11
相关论文
共 50 条
  • [31] OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion
    Esteve-Pitarch, Erika
    Padulles-Zamora, Ariadna
    Maisterra-Santos, Kristel
    Colom-Codina, Helena
    Cobo-Sacristan, Sara
    Daniel Gumucio-Sanguino, Victor
    Farre-Estebe, Anna
    Anguela-Calvet, Laura
    Sabater-Riera, Joan
    Perez-Fernandez, Xose
    Rojas-Lora, Mariel
    Rigo-Bonin, Raul
    Tubau-Quintano, Fe
    Shaw-Perujo, Evelyn
    FARMACIA HOSPITALARIA, 2019, 43 (05) : 151 - 157
  • [32] Suboptimal Beta-Lactam Therapy in Critically Ill Children: Risk Factors and Outcome*
    Van der Heggen, Tatjana
    Dhont, Evelyn
    Willems, Jef
    Herck, Ingrid
    Delanghe, Joris R.
    Stove, Veronique
    Verstraete, Alain G.
    Vanhaesebrouck, Sophie
    De Paepe, Peter
    De Cock, Pieter A. J. G.
    PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (07) : E309 - E318
  • [33] Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort Analysis
    Gijsen, Matthias
    Dreesen, Erwin
    Annaert, Pieter
    Nicolai, Johan
    Debaveye, Yves
    Wauters, Joost
    Spriet, Isabel
    MICROORGANISMS, 2021, 9 (06)
  • [34] Does Two-Step Infusion Improve the Pharmacokinetics/Pharmacodynamics Target Attainment of Meropenem in Critically Ill Patients?
    Chen, Jiaojiao
    Wang, Quanfang
    Li, Sihan
    Han, Ruiying
    Wang, Chuhui
    Cheng, Shiqi
    Yang, Baogui
    Diao, Lizhuo
    Yang, Tingting
    Sun, Dan
    Zhang, Di
    Dong, Yalin
    Wang, Taotao
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 113 (09) : 2904 - 2914
  • [35] Cefepime Population Pharmacokinetics and Target Attainment in Critically Ill Patients on Continuous Renal Replacement Therapy
    Al-Shaer, Mohammad H.
    Philpott, Carolyn D.
    Droege, Christopher A.
    Courter, Joshua D.
    Healy, Daniel P.
    Droege, Molly E.
    Ernst, Neil E.
    Mueller, Eric W.
    Peloquin, Charles A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (06)
  • [36] Cefepime Population Pharmacokinetics, Antibacterial Target Attainment, and Estimated Probability of Neurotoxicity in Critically Ill Patients
    Bilal, Muhammad
    Zoller, Michael
    Fuhr, Uwe
    Jaehde, Ulrich
    Ullah, Sami
    Liebchen, Uwe
    Buesker, Soeren
    Zander, Johannes
    Babouee Flury, Baharak
    Taubert, Max
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (07)
  • [37] Adverse events during intrahospital transport of critically ill patients: incidence and risk factors
    Erika Parmentier-Decrucq
    Julien Poissy
    Raphaël Favory
    Saad Nseir
    Thierry Onimus
    Mary-Jane Guerry
    Alain Durocher
    Daniel Mathieu
    Annals of Intensive Care, 3
  • [38] Adverse events during intrahospital transport of critically ill patients: incidence and risk factors
    Parmentier-Decrucq, Erika
    Poissy, Julien
    Favory, Raphael
    Nseir, Saad
    Onimus, Thierry
    Guerry, Mary-Jane
    Durocher, Alain
    Mathieu, Daniel
    ANNALS OF INTENSIVE CARE, 2013, 3 : 1 - 10
  • [39] High rates of cefidercol plasma target attainment: results of a retrospective cohort study in 31 critically ill ICU patients
    Naumann, Hans Theodor
    Hoehl, Rainer
    Kinzig, Martina
    Salat, Sophie
    Bartsch, Vanessa
    Soergel, Fritz
    Bertram, Ralph
    Steinmann, Joerg
    Therapeutic Drug Monitoring study grp, Arnim
    CRITICAL CARE, 2024, 28 (01)
  • [40] Reprint of: Does two-step infusion improve the pharmacokinetics/pharmacodynamics target attainment of meropenem in critically Ill patients?
    Chen, Jiaojiao
    Wang, Quanfang
    Li, Sihan
    Han, Ruiying
    Wang, Chuhui
    Cheng, Shiqi
    Yang, Baogui
    Diao, Lizhuo
    Yang, Tingting
    Sun, Dan
    Zhang, Di
    Dong, Yalin
    Wang, Taotao
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 114 (01) : 165 - 175
12345